TI
JUNO

Turner Investments’s Juno Therapeutics, Inc. JUNO Stock Holding History

Turner Investments’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-27,670
Closed -$830K – 308
2016
Q3 		$830K Buy
+27,670
New +$861K 0.27% 118
2016
Q1 		– Sell
-1,500
Closed -$66K – 290
2015
Q4 		$66K Sell
1,500
-68,180
-98% -$3.38M 0.01% 211
2015
Q3 		$2.83M Buy
+69,680
New +$3.06M 0.57% 57

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Turner Investments's JUNO Position: Q4 2016 in Review

Turner Investments sold out of Juno Therapeutics, Inc. (JUNO) in Q4 2016, closing a stake of 27,670 shares — an estimated $830K sold.

Turner Investments first reported a position in JUNO in Q3 2015 and held it in 3 quarters. The position peaked at $2.83M in Q3 2015. 159 funds tracked by Wall St. Rank hold JUNO as of Q4 2016.

  • Turner Investments reported no remaining Juno Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Turner Investments sold 27,670 Juno Therapeutics, Inc. shares in Q4 2016, an estimated $830K.
  • Turner Investments first reported a position in Juno Therapeutics, Inc. in Q3 2015 and held it in 3 quarters.
  • Turner Investments's Juno Therapeutics, Inc. position peaked at $2.83M in Q3 2015.
  • 159 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q4 2016.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.